素功能化纳米材料:用于阿尔茨海默病管理的创新治疗途径
Jinjin Pei1, Ranil Vikraman Kumarasamy2, Selvaraj Jayaraman3
1College of Food Science and Technology, Guangdong Provincial Key Laboratory of Aquatic Product Pro-cessing and Safety, Guangdong Province Engineering Laboratory for Marine Biological Products, Guang-dong Provincial Engineering Technology Research Center of Seafood, Guangdong Provincial Engineering Technology Research Center of Prefabricated Seafood Processing and Quality Control, Guangdong Ocean University, Zhanjiang 524088, China.
Ageing research reviews
|January 17, 2025
概括
奎尔塞丁是一种黄类化合物,在阿尔茨海默氏症 (AD) 治疗中显示出有前途. 纳米技术提高了向大脑输送氨酸的速度,克服了生物可用性和血脑屏障的挑战,以改善神经保护.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 阿尔茨海默氏症 (AD) 是一个重大的全球健康挑战,有效治疗方法有限.
- 奎尔西是一种黄类化合物,具有抗氧化,抗炎和神经保护性质,对AD有益.
- 奎尔的治疗应用受到生物利用性差,不稳定性和受限制的血脑屏障 (BBB) 透的限制.
研究的目的:
- 审查素功能化纳米材料的应用,以改善阿尔茨海默病的管理.
- 探索各种纳米载体系统,以优化整个BBB的Quercetin输送.
- 评估这些纳米结构的神经保护机制和治疗潜力.
主要方法:
- 关于基于纳米技术的AD的氏素输送系统现有文献的审查.
- 对纳米载体类型的分析,包括脂质体,聚合物纳米颗粒和基于金属的纳米系统.
- 对前临床和体外研究结果的检查,涉及Quercetin-loaded纳米结构.
主要成果:
- 纳米技术显著提高了奎尔素的可溶性,稳定性和BBB透性.
- 在临床前和体外模型中,含有奎尔素的纳米载体显示出增强的神经保护作用.
- 各种纳米载体系统显示了在AD中向切丁递送的潜力.
结论:
- 素功能化纳米材料提供了一个有前途的策略,以克服AD治疗中的交付挑战.
- 纳米技术的进步对于最大限度地提高瑞在神经退行性疾病中的治疗效果至关重要.
- 需要进一步的研究和临床转化,才能充分实现这些纳米疗法在阿尔茨海默病的潜力.
相关概念视频
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439


